A Zofran Case alleges Birth Defects were caused by the drug which a mother took while pregnant. Sonya Lampkin filed the lawsuit on behalf of her son, an unnamed minor in the petition filed March

A Zofran lawsuit was filed in Texas federal court April 17, 2015. It claims Zofran, an anti-nausea medication, can cause birth defects in babies born to mothers taking the drug during pregnancy. Filed in

The generic version of the drug Zofran is not equivalent to the brand version, ondansetron. In fact, no generic drug is equivalent to a brand drug, according to the U.S. Supreme Court. In 2011 –

Zofran Birth Defect Lawsuit Consolidation has been requested by GlaxoSmithKline (GSK), the maker of Zofran. GSK faces several lawsuits which allege that the drug maker failed to warn that taking the drug during the

Drugmaker GlaxoSmithKline knew Zofran pregnancy risks, yet marketed the drug to pregnant women anyway. GSK began to market Zofran to Americans in 1991. The company promoted Zofran “off-label,” for purposes which the FDA had

The mother of a baby born with a cleft lip after she took  Zofran in her first trimester filed a lawsuit against GlaxoSmithKline (GSK) on May 21, 2015. The suit charges the company failed

The anti-nausea drug Zofran increases birth defect risks, including heart defects, cleft lip and cleft palate. The FDA has not approved Zofran use for pregnant women. No long-term studies have proven Zofran (generic, Ondansetron)

Generic Drugs are not equivalent to Brand name drugs, according to the United States Supreme Court.  Any person who takes a brand-name drug is protected by tort law. If a brand-name drug turns out